natgillin/translations-raw huggingface dataset:
The Insuman Comb 25 cartridges are to be used only in conjunction with the pens: OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar or JuniorSTAR (see section 4.4).
Insuman Comb 25 ulošci smiju se upotrebljavati samo s brizgalicama OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar ili JuniorSTAR (vidjeti dio 4.4).
The Insuman Comb 25 cartridges are to be used only with the pens: OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
Insuman Comb 25 ulošci smiju se koristiti samo s brizgalicama OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
The Insuman Comb 25 cartridges should only be used with the following pens:
Insuman Comb 25 ulošci smiju se upotrebljavati samo sa sljedećim brizgalicama:
The Insuman Comb 30 cartridges are to be used only in conjunction with the pens: OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar or JuniorSTAR (see section 4.4).
Insuman Comb 30 ulošci smiju se upotrebljavati samo s brizgalicama OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar ili JuniorSTAR (vidjeti dio 4.4).
The Insuman Comb 30 cartridges are to be used only with the pens: OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
Insuman Comb 30 ulošci smiju se koristiti samo s brizgalicama OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
The Insuman Comb 30 cartridges should only be used with the following pens:
Insuman Comb 30 ulošci smiju se upotrebljavati samo sa sljedećim brizgalicama:
The Insuman comb 50 cartridges are to be used only in conjunction with the pens: OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar or JuniorSTAR (see section 4.4).
Insuman Comb 50 ulošci smiju se upotrebljavati samo s brizgalicama OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar ili JuniorSTAR (vidjeti dio 4.4).
The Insuman Comb 50 cartridges are to be used only with the pens: OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
Insuman Comb 50 ulošci smiju se koristiti samo s brizgalicama OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
The Insuman Comb 50 cartridges should only be used with the following pens:
Insuman Comb 50 ulošci smiju se upotrebljavati samo sa sljedećim brizgalicama:
The Insuman Rapid cartridges are to be used only in conjunction with the pens: OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar or JuniorSTAR (see section 4.4).
Insuman Rapid ulošci smiju se upotrebljavati samo s brizgalicama OptiPen, ClikSTAR, Autopen 24, Tactipen, AllStar ili JuniorSTAR (vidjeti dio 4.4).
The Insuman Rapid cartridges are to be used only with the pens: OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
Insuman Rapid ulošci smiju se koristiti samo s brizgalicama OptiPen, ClikSTAR, Tactipen, Autopen 24, AllStar, JuniorSTAR.
The Insuman Rapid cartridges should only be used with the following pens:
Insuman Rapid ulošci smiju se upotrebljavati samo sa sljedećim brizgalicama:
The intake of a single bait is sufficient to ensure active immunisation to prevent infection by rabies virus.
Za aktivnu imunizaciju lisica i kunopasa u cilju sprječavanja infekcije virusom bjesnoće.
The intake of St John’s Wort should be restricted during the treatment with ivabradine.
Tijekom liječenja s ivabradinom potrebno je ograničiti uzimanje Gospine trave.
The intended dose of 1.5 g/kg of PegIntron to be used in combination with ribavirin may be delivered in weight categories with the PegIntron strengths according to Table 1.
Potrebna doza od 1,5 µg/kg lijeka PegIntron koja će se primijeniti u kombinaciji s ribavirinom određuje se prema kategorijama tjelesne težine i odgovarajućim jačinama lijeka PegIntron, kako je navedeno u Tablici 1.
The intended therapy was 6 months dabigatran etexilate 150 mg twice daily without need for monitoring.
Ciljano liječenje bilo je primjena dabigatraneteksilata 150 mg dvaput dnevno bez potrebe za praćenjem u trajanju od 6 mjeseci.
The intensity and incidence of most side effects depends on the dose you are taking.
Težina i pojava većine nuspojave ovise o dozi koju uzimate.
The intensity of the local skin reactions tend to be lower in the second cycle than in the first treatment cycle with Zyclara.
Intenzitet lokalnih kožnih reakcija obično bude manji u drugom ciklusu nego u prvom ciklusu liječenja Zyclarom.
The intensity of the reflected signal is dependent on concentration of the microbubbles and frequency of the ultrasound beam.
Intenzitet reflektiranog signala ovisi o koncentraciji mikromjehurića i frekvenciji ultrazvučnog vala.
The intensity of these effects is dependent on the type of illumination used for photodynamic therapy.
Intenzitet tih djelovanja ovisi o tipu osvjetljavanja upotrijebljenog za fotodinamsku terapiju.
The inter-patient variability in a steady-state study in Alzheimer’s dementia was at most 45% (Cmax) and 43% (AUC0-24h) after use of the transdermal patch, and 71% and 73%, respectively, after administration of the oral form.
Varijabilnost između bolesnika s Alzheimerovom demencijom u stanju dinamičke ravnoteže bila je najviše 45% (Cmax) i 43% (AUC0-24h) nakon primjene transdermalnog flastera te 71% i 73% nakon primjene oralne formulacije.
The inter-patient variability of the population estimate for plasma clearance of trabectedin was 49% and intra-patient variability was 28%.
Varijabilnost između bolesnika za procjenu unutar populacije za plazmatski klirens trabektedina iznosila je 49 %, a varijabilnost za bolesnika iznosila je 28 %.
The interaction between daptomycin and tobramycin with an approved dose of Cubicin is unknown.
Nisu poznate interakcije daptomicina i tobramicina tijekom primjene Cubicina u odobrenoj dozi.
The interaction between nevirapine and the antithrombotic agent warfarin is complex, with the potential for both increases and decreases in coagulation time when used concomitantly.
Interakcije između nevirapina i antitrombotika varfarina su kompleksne, s potencijalom za povećanje i za smanjenje vremena
The interaction of dronedarone on calcium antagonists is described above (see section 4.4).
Interakcija dronedarona i antagonista kalcija opisana je prethodno (vidjeti dio 4.4).
The interaction profile of darunavir depends on whether ritonavir or cobicistat is used as pharmacokinetic enhancer.
Profil interakcija darunavira ovisan je o tome je li kao farmakokinetički pojačivač primijenjen ritonavir ili kobicistat.
The interaction profiles of HIV-protease inhibitors, co-administered with low dose ritonavir, are dependent on the specific co-administered protease inhibitor.
Profil interakcija inhibitora HIV-proteaza, kada se daju istodobno s ritonavirom u malim dozama, ovisi o određenom inhibitoru proteaza koji se daje.
The interactions described are based on studies conducted with Genvoya, or the components of Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide), as individual agents and/or in combination, or are potential drug-drug interactions that may occur with Genvoya.
Opisane interakcije temelje se na ispitivanjima koja su provedena s lijekom Genvoya ili komponentama lijeka Genvoya (elvitegraviru, kobicistatu, emtricitabinu i tenofoviralafenamidu) kao pojedinačnim tvarima i/ili u kombinaciji, ili su potencijalne interakcije lijekova koje se mogu pojaviti s lijekom Genvoya.
The interface between the sulphur hexafluoride bubble and the aqueous medium acts as a reflector of the ultrasound beam thus enhancing blood echogenicity and increasing contrast between the blood and the surrounding tissues.
Granica između mjehurića sumporovog heksafluorida i vodenog medija djeluje kao reflektor ultrazvučnih valova i tako povećava ehogenost krvi te pojačava kontrast između krvi i okolnih tkiva.
The interference mitigation methods include treating reagent RBCs with dithiothreitol (DTT) to disrupt daratumumab binding or other locally validated methods.
Metode za ublažavanje interferencije daratumumaba uključuju tretiranje reagentnih eritrocita ditiotreitolom (DTT-om) kako bi se prekinulo vezanje daratumumaba ili druge lokalno validirane metode.
The interferon alfa-2a in Pegasys is produced by a method known as ‘recombinant DNA technology’: it is made by bacteria into which a gene (DNA) has been introduced, which makes them able to produce interferon alfa-2a.
Interferon alfa-2a u lijeku Pegasys proizvodi se metodom poznatom pod nazivom „tehnologija rekombinantne DNK” i nastaje u bakterijama u koje se uvodi gen (DNK), što ih čini sposobnim za proizvodnju interferona alfa-2a.
The interferon in Plegridy is produced by a method known as ‘recombinant DNA technology’.
Interferon u lijeku Plegridy proizvodi se metodom poznatom pod nazivom „tehnologija rekombinatne DNK”.
The interim OS analysis did not meet the protocol-specified early stopping boundary for OS (p ≤ 0.014).
Interim analiza OS-a nije dosegla protokolom specificiranu graničnu vrijednost OS-a za rani prekid (p ≤ 0,014).
The interim reports will be submitted every two years until the final patient is followed for 5 years.
Prijevremena izvješća podnosit će se svake dvije godine sve dok i posljednji bolesnik ne bude praćen 5 godina.
The interpatient variability in pharmacokinetic parameters for zoledronic acid was high, as seen with other bisphosphonates.
Farmakokinetički parametri zoledronatne kiseline, viđenih i koddrugih bisfosfonata, uvelike se razlikuju između pojedinih bolesnika.
The interval between each injection should be at least 1 month.
Razmak između svake injekcije treba biti najmanje 1 mjesec.
The interval between each injection should be at least 2 months
Razmak između svake injekcije treba biti najmanje 2 mjeseca.
The interval between each injection should be at least 2 months.
Razmak između svake injekcije treba biti najmanje 2 mjeseca.
The interval between the injections should be at least 2 months.
Razmak između injekcija mora biti najmanje 2 mjeseca.
The interval between the last maintenance dose and the first re- induction dose ranged from 35-231 days.
Interval između zadnje doze održavanja i prve doze ponovljenog uvodnog režima liječenja kretao se od 35 do 231 dana.
The interval between the pneumococcal conjugate vaccine (Prevenar) and the 23- valent pneumococcal polysaccharide vaccine should not be less than 8 weeks.
Vremenski razmak između pneumokoknog konjugiranog cjepiva (Prevenar) i 23-valentnog pneumokoknog polisaharidnog cjepiva ne smije biti manji od 8 tjedana.
The interval between the pneumococcal conjugate vaccine (Prevenar) and the 23- valent pneumococcal polysaccharide vaccine should not be less than 8 weeks.
Vremenski razmak između primjene konjugiranog pneumokoknog cjepiva (Prevenar) i 23-valentnog polisaharidnog pneumokoknog cjepiva ne smije biti manji od 8 tjedana.
The interval between two doses injected into the same eye should be at least four weeks.
Razmak između dviju doza injiciranih u isto oko treba biti najmanje četiri tjedna.
The interval between two doses should not be shorter than one month.
Vremenski razmak između dvije doze ne smije biti kraći od jednog mjeseca.
The interval between two injections of Lucentis into the same eye must be at least four weeks.
Interval između dvije injekcije lijeka Lucentis u isto oko treba biti bar četiri tjedna.
The intra-individual variability in time to maximum concentration is significantly less for NovoRapid than for soluble human insulin, whereas the intra- individual variability in Cmax for NovoRapid is larger.
Intraindividualna varijabilnost u vremenu potrebnom da se postigne maksimalna koncentracija značajno je manja za NovoRapid nego za otopinu humanog inzulina, dok je intraindividualna varijabilnost u Cmax veća za NovoRapid.
The intra-subject coefficients of variation for saxagliptin Cmax and AUC were less than 12 %.
Intraindividualni koeficijenti varijacije za Cmax i AUC saksagliptina bili su manji od 12%.
The intra-subject coefficients of variation for saxagliptin Cmax and AUC were less than 12%.
Intraindividualni koeficijenti varijacije za Cmax i AUC saksagliptina bili su manji od 12%.
The intra-subject coefficients of variation for saxagliptin Cmax and AUC were less than 12%.
Koeficijenti varijacije unutar ispitanika za Cmax i AUC saksagliptina bili su manji od 12%.
The intracellular anabolism of 6-merpactopurine is catalysed by several enzymes to eventually form 6-thioguanine nucleotides (TGNs), but a variety of intermediary TGNs are formed en route to the TGNs.
Unutarstaničnu dogradnju 6- merkaptopurina katalizira nekoliko enzima do konačnog stvaranja nukleotida 6-tiogvanina, ali pri tome nastaje niz međuspojeva nukleotida 6-tiogvanina.
The intracellular bactericidal activity of bedaquiline in primary peritoneal macrophages and in a macrophage-like cell line was greater than its extracellular activity.
Unutarstanična baktericidna aktivnost bedakilina u primarnim peritonelanim makrofagima i u linijama stanicama sličnim makrofagima bila je veća nego njegova izvanstanična aktivnost.
The intranasal dosing of 110 micrograms once daily does not typically result in measurable plasma concentrations (<10 pg/ml).
Intranazalno doziranje od 110 mikrograma jednom na dan obično ne rezultira mjerljivim koncentracijama u plazmi (<10 pg/ml).
The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure which has been associated with lactic acidosis in patients receiving metformin.
Intravaskularna primjena jodnih kontrastnih sredstava pri radiološkim pretragama može dovesti do zatajenja bubrega, koje se u bolesnika koji primaju metformin povezuje s laktacidozom.
The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure which has been associated with lactic acidosis in patients receiving metformin.
U bolesnika koji primaju metformin, intravaskularna primjena kontrastnog sredstva koje sadrži jod u radiološkim pretragama može dovesti do zatajenja bubrega povezanog s laktacidozom.
The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure which has been associated with lactic acidosis in patients receiving metformin.
U bolesnika koji uzimaju metformin intravaskularna primjena kontrastnog sredstva koje sadrži jod u radiološkim pretragama može dovesti do zatajenja bubrega povezanog s laktacidozom.
The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure which has been associated with lactic acidosis in patients receiving metformin.
U bolesnika koji uzimaju metformin, intravaskularna primjena kontrastnog sredstva koje sadrži jod u radiološkim pretragama može dovesti do zatajenja bubrega povezanog s laktacidozom.
The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure.
Intravaskularna primjena jodnih kontrastnih sredstava u radiološkim pretragama može dovesti do zatajivanja bubrega.
The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure.
Intravaskularna primjena jodnih kontrastnih sredstava zbog radioloških pretraga može dovesti do zatajenja bubrega.
The intravascular administration of iodinated contrast agents in radiological studies can lead to renal failure.
Intravaskularna primjena kontrastnih sredstava koja sadrže jod u radiološkim ispitivanjima može uzrokovati zatajenje bubrega.
The intravascular administration of iodinated contrast agents in radiological studies may lead to renal failure, resulting in metformin accumulation and a risk of lactic acidosis.
Intravaskularna primjena jodiranih kontrastnih sredstava u radiološkim ispitivanjima mogu dovesti do zatajenja bubrega, što rezultira nakupljanjem metformina i rizikom od laktacidoze.
The intravascular administration of iodinated contrast agents in radiological studies may lead to renal failure, resulting in metformin accumulation and a risk of lactic acidosis.
Intravaskularna primjena kontrastnog sredstva koje sadrži jod u radiološkim pretragama može dovesti do zatajenja bubrega, a time i do nakupljanja metformina i rizika od laktacidoze.
The intravascular administration of iodinated contrast agents in radiological studies may lead to renal failure, resulting in metformin accumulation and a risk of lactic acidosis.
Intravaskularna primjena kontrastnog sredstva koje sadrži jod u radiološkim pretragama može dovesti do zatajenja bubrega, što rezultira akumulacijom metformina i rizikom od razvoja laktacidoze.
The intravascular administration of iodinated contrast agents may lead to renal failure resulting in metformin accumulation and a risk of lactic acidosis.
Intravaskularna primjena jodnih kontrastnih sredstava može dovesti do zatajenja bubrega i rezultirati nakupljanjem metformina i rizikom od laktacidoze.
The intravascular administration of iodinated contrast media in radiologic studies can lead to renal failure.
Intravaskularna primjena jodiranih kontrastnih sredstava u radiološkim ispitivanjima može dovesti do zatajenja bubrega.
The intravenous access line or cannula must be flushed with isotonic sodium chloride 9 mg/mL (0.9%) solution for injection before and after injection of Xofigo.
Linija ili kanila za intravenski pristup mora biti isprana s izotoničnom otopinom natrijevog klorida 9 mg/ml (0,9%) za injekciju prije i nakon injekcije lijeka Xofigo.
The intravenous administration of doses up to 4,000 mg diluted in 100 ml of 0.9 % sodium chloride infused over 15 minutes and doses up to 2,500 mg diluted in 100 ml of 0.9 % sodium chloride infused over 5 minutes was evaluated.
Procjenjivana je intravenska primjena doza do 4000 mg razrijeđenih u 100 ml 0,9% otopine natrijevog klorida danih infuzijom tijekom 15 minuta i doza do 2500 mg razrijeđenih u 100 ml 0,9% otopine natrijevog klorida danih infuzijom tijekom 5 minuta.
The intravenous formulation is an alternative to your oral administration.
Intravenska formulacija je alternativa primjeni lijeka kroz usta.
The intravenous infusion set provided in the kit must then be used as it includes an appropriate filter and is to be primed with the reconstituted solution.
Iz tog razloga mora se koristiti set za intravensku infuziju koji se nalazi u priboru jer uključuje odgovarajući filtar te ga treba pripremiti rekonstituiranom otopinom.
The intravenous vehicle, SBECD, is haemodialysed with a clearance of 55 ml/min.
Intravenski vehikulum SBECD odstranjuje se hemodijalizom klirensom od 55 ml/min.
The intravitreal injection of JETREA may be followed by temporary visual disturbances (see section 4.8).
Nakon intravitrealne injekcije JETREE mogući su privremeni poremećaji vida (vidjeti dio 4.8).
The intravitreal injection procedure should be carried out under controlled aseptic conditions, which include the use of surgical hand disinfection, sterile gloves, a sterile drape, a sterile eyelid speculum (or equivalent) and the availability of sterile paracentesis (if required).
Postupak davanja intravitrealne injekcije mora se obaviti u nadziranim aseptičkim uvjetima, uključujući kiruršku dezinfekciju ruku, korištenje sterilnih rukavica, sterilnog ogrtača, sterilnog spekuluma za vjeđe (ili drugi ekvivalent) i dostupnost sterilne paracenteze (u slučaju potrebe).
The intravitreal procedure as it was performed in the pivotal clinical studies, along with any technical improvements
intravitrealni postupak kako je proveden u pivot kliničkim ispitivanjima skupa s tehničkim poboljšanjima
The intravitreal toxicity of ocriplasmin has been evaluated in rabbits, monkeys and minipigs.
Intravitrealna toksičnost okriplazmina ispitana je u kunića, majmuna i patuljastih svinja.
The intra­subject coefficient of variation for liraglutide AUC was 11% following single dose administration.
Intraindividualni koeficijent varijacije za AUC liraglutida bio je 11% nakon primjene jedne doze.
The investigator assessed confirmed response rate in patients with BRAF V600E metastatic melanoma (n=76) was 59% (95% CI: 48.2, 70.3) and the median duration of response was 5.2 months (95% CI: 3.9, not calculable) based on a median follow-up time of 6.5 months.
Potvrđena stopa odgovora prema procjeni ispitivača u bolesnika s BRAF V600E metastatskim melanomom (n=76) iznosila je 59% (95% CI: 48,2; 70,3), a medijan trajanja odgovora 5,2 mjeseca (95% CI: 3,9; nije bilo moguće izračunati) temeljem medijana vremena praćenja od 6,5 mjeseci.
The investigator assessment of PFS was consistent with a blinded independent central radiological review of PFS.
Ispitivačeva procjena PFS-a bila je u skladu sa zaslijepljenom neovisnom centraliziranom radiološkom procjenom PFS-a.
The investigator radiographic review of rPFS performed as a follow up sensitivity analysis is presented in Table 3 and Figure 2.
Radiografski pregled ispitivača rPFS proveden kao nastavna analiza osjetljivosti, prikazan je u Tablici 3 i na Slici 2.
The investigators also found esomeprazole to be significantly more effective than placebo in resolving acid regurgitation (58.5% - 63.6% vs placebo 28.3% - 37.4%) during the week 2 evaluation.
Ispitivači su također pronašli da je esomeprazol znatno djelotvorniji od placeba u liječenju regurgitacije kiseline (58,5%-63,6% u odnosu na 28,3%-37,4% bolesnika koji su primali placebo) tijekom procjene u tjednu 2.
The investigators’ assessments of heartburn resolution were consistent with the subjects’ assessments, showing statistically significant differences between esomeprazole (34.7% - 41.8%) compared to placebo (8.0% - 11.4%).
Ispitivačeve procjene povlačenja žgaravice bile su dosljedne ispitanikovim procjenama pokazujući statistički značajne razlike između esomeprazola (34,7% do 41,8%) u usporedbi s placebom (8,0%- 11,4%).
The Investigator’s assessment of successful outcome at each of these time points is shown in the following table.
Procjena ispitivača o uspješnosti liječenja u svakoj od navedenih vremenskih točaka prikazana je u sljedećoj tablici:
The investigator’s choice treatment was selected before randomization and consisted of monotherapy with either chlorambucil, cytarabine, rituximab, fludarabine, or gemcitabine.
Liječenje prema izboru liječnika ispitivača izabrano je prije randomizacije, a sastojalo se od monoterapije klorambucila, citarabina, rituksimaba, fludarabina ili gemcitabina.
The involvement of other enzymes (e.g.
Uključenost ostalih enzima (npr.
The iron levels of all patients should be checked before treatment to make sure that they are not too low, and iron supplements should be used throughout treatment.
Koncentracije željeza svih bolesnika trebaju biti provjerene prije terapije kako bi se osiguralo da nisu preniske, a dodatci željeza trebaju se koristiti tijekom terapije.
The iron uptake from radiolabelled Velphoro drug substance, 2,000 mg in 1 day was investigated in 16 CKD patients (8 pre-dialysis and 8 haemodialysis patients) and 8 healthy volunteers with low iron stores (serum ferritin <100 mcg/L).
Apsorpcija željeza iz radioaktivno označene djelatne tvari lijeka Velphoro, 2000 mg u 1 danu, istražena je u 16 bolesnika s KBB­om (8 bolesnika u predijalizi i 8 na hemodijalizi) i 8 zdravih dobrovoljaca s niskim zalihama željeza (serumski feritin <100 μg/l).
The isolated rash should be closely monitored (see section 4.4).
Izolirani se osip mora pomno pratiti (vidjeti dio 4.4.).
The isolated rash should be closely monitored (see section 4.4).
Izolirani slučajevi osipa moraju se pomno pratiti (vidjeti dio 4.4).
The IUO is an allele-specific polymerase chain reaction (PCR) assay performed on DNA extracted from formalin-fixed paraffin-embedded (FFPE) tumour tissue.
IUO je alel-specifičan test lančane reakcije polimerazom (PCR) koji se provodi na DNK izolirane iz tumorskog tkiva fiksiranog u formalinu i uklopljenog u parafin (engl. formalin-fixed, paraffin-embedded, FFPE).
The IV bolus injection may be given rapidly and directly into a vein or into an existing IV line.
Može se dati brzom i.v. bolus injekcijom izravno u venu ili u postavljenu i.v. liniju.
The jar is closed and carefully shaken until all the powder has dissolved completely.
Zatvoriti posudicu i pažljivo ju protresti, sve dok se prašak potpuno ne otopi.
The jar labelled “13C-urea powder” is removed from the pack, opened, and filled up to about three quarters with tap water.
Iz pakiranja izvaditi posudicu s naljepnicom „13C-urea prašak“, otvoriti je i napuniti običnom vodom do tri četvrtine zapremine.